<?xml version="1.0" encoding="us-ascii"?><InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><Version>2.2.0.25</Version><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios><ReportLongName>0221 - Disclosure - Commitments and Contingencies</ReportLongName><DisplayLabelColumn>true</DisplayLabelColumn><ShowElementNames>false</ShowElementNames><RoundingOption /><HasEmbeddedReports>false</HasEmbeddedReports><Columns><Column><Id>1</Id><IsAbstractGroupTitle>false</IsAbstractGroupTitle><LabelColumn>false</LabelColumn><CurrencyCode>USD</CurrencyCode><FootnoteIndexer /><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios><MCU><KeyName>1/1/2010 - 12/31/2010
USD ($) / shares

USD ($)

</KeyName><CurrencySymbol>$</CurrencySymbol><contextRef><ContextID>Jan-01-2010_Dec-31-2010</ContextID><EntitySchema>http://www.sec.gov/CIK</EntitySchema><EntityValue>0000780053</EntityValue><PeriodDisplayName /><PeriodType>duration</PeriodType><PeriodStartDate>2010-01-01T00:00:00</PeriodStartDate><PeriodEndDate>2010-12-31T00:00:00</PeriodEndDate><Segments /><Scenarios /></contextRef><UPS><UnitProperty><UnitID>USDEPS</UnitID><UnitType>Divide</UnitType><NumeratorMeasure><MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema><MeasureValue>USD</MeasureValue><MeasureNamespace>iso4217</MeasureNamespace></NumeratorMeasure><DenominatorMeasure><MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema><MeasureValue>shares</MeasureValue><MeasureNamespace>xbrli</MeasureNamespace></DenominatorMeasure><Scale>0</Scale></UnitProperty><UnitProperty><UnitID>USD</UnitID><UnitType>Standard</UnitType><StandardMeasure><MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema><MeasureValue>USD</MeasureValue><MeasureNamespace>iso4217</MeasureNamespace></StandardMeasure><Scale>0</Scale></UnitProperty><UnitProperty><UnitID>Shares</UnitID><UnitType>Standard</UnitType><StandardMeasure><MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema><MeasureValue>shares</MeasureValue><MeasureNamespace>xbrli</MeasureNamespace></StandardMeasure><Scale>0</Scale></UnitProperty></UPS><CurrencyCode>USD</CurrencyCode><OriginalCurrencyCode>USD</OriginalCurrencyCode></MCU><CurrencySymbol>$</CurrencySymbol><Labels><Label Id="1" Label="12 Months Ended" /><Label Id="2" Label="Dec. 31, 2010" /></Labels></Column></Columns><Rows><Row><Id>2</Id><IsAbstractGroupTitle>true</IsAbstractGroupTitle><Level>0</Level><ElementName>nhp_CommitmentsAndContingenciesAbstract</ElementName><ElementPrefix>nhp</ElementPrefix><IsBaseElement>false</IsBaseElement><BalanceType>na</BalanceType><PeriodType>duration</PeriodType><ShortDefinition>Commitments and Contingencies.</ShortDefinition><IsReportTitle>false</IsReportTitle><IsSegmentTitle>false</IsSegmentTitle><IsSubReportEnd>false</IsSubReportEnd><IsCalendarTitle>false</IsCalendarTitle><IsTuple>false</IsTuple><IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow><IsEquityAdjustmentRow>false</IsEquityAdjustmentRow><IsBeginningBalance>false</IsBeginningBalance><IsEndingBalance>false</IsEndingBalance><IsReverseSign>false</IsReverseSign><PreferredLabelRole /><FootnoteIndexer /><Cells><Cell><Id>1</Id><IsNumeric>false</IsNumeric><IsRatio>false</IsRatio><DisplayZeroAsNone>false</DisplayZeroAsNone><NumericAmount>0</NumericAmount><RoundedNumericAmount>0</RoundedNumericAmount><NonNumbericText /><NonNumericTextHeader /><FootnoteIndexer /><CurrencyCode /><CurrencySymbol /><IsIndependantCurrency>false</IsIndependantCurrency><ShowCurrencySymbol>false</ShowCurrencySymbol><DisplayDateInUSFormat>false</DisplayDateInUSFormat><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios></Cell></Cells><OriginalInstanceReportColumns /><Unit>Other</Unit><ElementDataType>xbrli:stringItemType</ElementDataType><SimpleDataType>string</SimpleDataType><ElementDefenition>Commitments and Contingencies.</ElementDefenition><IsTotalLabel>false</IsTotalLabel><IsEPS>false</IsEPS><Label>Commitments and Contingencies [Abstract]</Label></Row><Row><Id>3</Id><IsAbstractGroupTitle>false</IsAbstractGroupTitle><Level>0</Level><ElementName>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</ElementName><ElementPrefix>us-gaap</ElementPrefix><IsBaseElement>true</IsBaseElement><BalanceType>na</BalanceType><PeriodType>duration</PeriodType><ShortDefinition>No definition available.</ShortDefinition><IsReportTitle>false</IsReportTitle><IsSegmentTitle>false</IsSegmentTitle><IsSubReportEnd>false</IsSubReportEnd><IsCalendarTitle>false</IsCalendarTitle><IsTuple>false</IsTuple><IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow><IsEquityAdjustmentRow>false</IsEquityAdjustmentRow><IsBeginningBalance>false</IsBeginningBalance><IsEndingBalance>false</IsEndingBalance><IsReverseSign>false</IsReverseSign><PreferredLabelRole>verboselabel</PreferredLabelRole><FootnoteIndexer /><Cells><Cell><Id>1</Id><IsNumeric>false</IsNumeric><IsRatio>false</IsRatio><DisplayZeroAsNone>false</DisplayZeroAsNone><NumericAmount>0</NumericAmount><RoundedNumericAmount>0</RoundedNumericAmount><NonNumbericText>&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
   &lt;!-- Begin Block Tagged Note 21 - us-gaap:CommitmentsAndContingenciesDisclosureTextBlock--&gt;
   &lt;div style="margin-left: 0%"&gt;
   &lt;table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent; text-align: left"&gt;
   &lt;tr&gt;
       &lt;td width="5%"&gt;&lt;/td&gt;
       &lt;td width="95%"&gt;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr valign="top"&gt;
       &lt;td&gt;
       &lt;b&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;21.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/b&gt;
   &lt;/td&gt;
       &lt;td&gt;
       &lt;b&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;Commitments
       and Contingencies&lt;/font&gt;&lt;/b&gt;
   &lt;/td&gt;
   &lt;/tr&gt;
   &lt;/table&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
       &lt;b&gt;&lt;i&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;Litigation&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       From time to time, we are a party to various legal proceedings,
       lawsuits and other claims (as to some of which we may not be
       insured) that arise in the normal course of our business.
       Regardless of their merits, these matters may require us to
       expend significant financial resources. Except as described
       herein, we are not aware of any other legal proceedings or
       claims that we believe may have, individually or taken together,
       a material adverse effect on our business, results of operations
       or financial position. However, we are unable to predict the
       ultimate outcome of pending litigation and claims, and if our
       assessment of our liability with respect to these actions and
       claims is incorrect, such actions and claims could have a
       material adverse effect on our business, results of operations
       or financial position.
   &lt;/div&gt;
   &lt;div style="margin-top: 12pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
       &lt;b&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;Greenwood
       Healthcare Center&lt;/font&gt;&lt;/b&gt;
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       In late 2004 and early 2005, we were served with several
       lawsuits in connection with a fire at the Greenwood Healthcare
       Center in Hartford, Connecticut, that occurred on
       February&amp;#160;26, 2003. At the time of the fire, the Greenwood
       Healthcare Center was owned by us and leased to and operated by
       Lexington Healthcare Group (&amp;#8220;Lexington Healthcare&amp;#8221;).
       There were a total of 13 lawsuits arising from the fire. Those
       suits have been filed by representatives of patients who were
       either killed or injured in the fire. The lawsuits seek
       unspecified monetary damages. The complaints allege that the
       fire was set by a resident who had previously been diagnosed
       with depression. The complaints allege theories of negligent
       operation and premises liability against Lexington Healthcare,
       as operator, and us as owner. Lexington Healthcare has filed for
       bankruptcy. The matters have been consolidated into one action
       in the Connecticut Superior Court Complex Litigation Docket at
       the Judicial District at Hartford and are in various stages of
       discovery and motion practice. We have filed a motion for
       summary judgment with regard to certain pending claims and will
       be filing additional summary judgment motions for any remaining
       claims. Mediation was commenced with respect to most of the
       claims, and a settlement has been reached in 10 of the 13
       pending claims within the limits of our commercial general
       liability insurance. We obtained a judgment of nonsuit in one
       case whereby it is now dismissed, and the two remaining claims
       will be subject to summary judgment motions and ongoing efforts
       at resolution. Summary judgment rulings are not expected until
       the end of 2011, if not later.
   &lt;/div&gt;
   &lt;!-- XBRL Pagebreak Begin --&gt;
   &lt;/div&gt;
   &lt;!-- END PAGE WIDTH --&gt;
   &lt;!-- PAGEBREAK --&gt;
   &lt;div style="margin-left: 0%"&gt;
   &lt;!-- BEGIN PAGE WIDTH --&gt;
   &lt;div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
   &lt;b&gt;
   &lt;font style="font-family: 'Times New Roman', Times"&gt;
   &lt;/font&gt;
   &lt;/b&gt;
   &lt;/div&gt;
   &lt;div style="margin-top: 0pt; font-size: 1pt"&gt;
   &lt;/div&gt;
   &lt;div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
   &lt;b&gt;
   &lt;font style="font-family: 'Times New Roman', Times"&gt;
   &lt;/font&gt;
   &lt;/b&gt;
   &lt;/div&gt;
   &lt;div align="center" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
   &lt;b&gt;
   &lt;font style="font-family: 'Times New Roman', Times"&gt;
   &lt;/font&gt;
   &lt;/b&gt;
   &lt;/div&gt;
   &lt;!-- XBRL Pagebreak End --&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       Lexington Insurance, the insurance carrier for Lexington
       Healthcare, which potentially owes insurance coverage for these
       claims to us, has filed a lawsuit against us which seeks no
       monetary damages, but which does seek a court order limiting its
       insurance coverage obligations to us. We have filed a
       counterclaim against Lexington Insurance demanding additional
       insurance coverage from Lexington Insurance in amounts up to
       $10.0&amp;#160;million. The parties to that case, which is pending
       on the Complex Litigation Docket for the Judicial District of
       Hartford, filed cross-motions for summary judgment. Those
       motions have been decided, resulting in an outcome that is
       largely favorable for us. The court&amp;#8217;s ruling indicates
       $10.0&amp;#160;million in aggregate coverage is available from
       Lexington Insurance for both the various plaintiffs&amp;#8217; claims
       and our claims under the Professional Liability part of the
       Lexington Insurance policy. The court then found that there were
       13 separate medical incidents for each of the 13
       plaintiffs&amp;#8217; claims. However, the court limited the coverage
       to $500,000 per claim with a $250,000 self insured retention per
       claim, which retention will not be paid due to the bankruptcy of
       Lexington Healthcare. Further, the court has ruled that both the
       various plaintiffs&amp;#8217; claims and our claims are subject to
       the same policy limits. The court declined to find coverage for
       our claims under the comprehensive general liability portions of
       the Lexington Insurance policy. Lexington Insurance is pursuing
       an appeal of the rulings. We are currently defending the appeal
       by Lexington Insurance. We do not expect the appeal to be
       resolved before the end of 2011, if not later.
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       We are being defended in the matter by our commercial general
       liability carrier. We believe that we have substantial defenses
       to the claims and that we have adequate insurance to cover the
       risks, should liability nonetheless be imposed. However, because
       the remaining claims are still in the process of discovery and
       motion practice, it is not possible to predict the ultimate
       outcome of these claims.
   &lt;/div&gt;
   &lt;div style="margin-top: 12pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
       &lt;b&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;Shareholder
       Litigation&lt;/font&gt;&lt;/b&gt;
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       On February&amp;#160;28, 2011, a putative class action entitled
       &lt;i&gt;Palma&amp;#160;v. Nationwide Health Properties, Inc. et al.&lt;/i&gt;,
       was filed purportedly on behalf of our stockholders in the
       Superior Court of the State of California, Orange County
       Superior Court. It names us and members of our Board of
       Directors as defendants. The complaint alleges, among other
       things, that our directors breached their fiduciary duties by
       approving a proposed merger transaction between us and Ventas,
       Inc. (&amp;#8220;Ventas&amp;#8221;) because the proposed transaction would
       not maximize shareholder value and would allegedly provide the
       directors personal benefits not shared by our shareholders.
       Along with other relief, the complaint seeks an injunction
       against the closing of the proposed merger.
   &lt;/div&gt;
   &lt;div style="margin-top: 12pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
       &lt;b&gt;&lt;i&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;Development
       Agreements&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       During 2010, we entered into Mission Hills JV to develop a
       medical office building (see Note&amp;#160;5)&amp;#160;and entered into
       other agreements to develop a skilled nursing facility (see
       Note&amp;#160;3)&amp;#160;and to fund the expansion of a skilled nursing
       facility securing a mortgage loan (see Note&amp;#160;4). As of
       December&amp;#160;31, 2010, we had committed to fund an additional
       $50.8&amp;#160;million under these agreements, of which
       $36.4&amp;#160;million relates to Mission Hills JV and is expected
       to be funded through a third party construction loan.
   &lt;/div&gt;
   &lt;div style="margin-top: 12pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
       &lt;b&gt;&lt;i&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;Revolving
       Loan Facility&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       In 2009, we entered into an agreement with Brookdale under which
       we became a lender with an initial commitment of
       $8.8&amp;#160;million under their $230.0&amp;#160;million revolving loan
       facility (see Note&amp;#160;4). During 2009, we funded
       $7.5&amp;#160;million which was subsequently repaid. As of
       December&amp;#160;31, 2009, there was no balance outstanding. The
       revolving loan facility was terminated as of February&amp;#160;23,
       2010. There was no balance outstanding at the date of
       termination.
   &lt;/div&gt;
   &lt;div style="margin-top: 12pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
       &lt;b&gt;&lt;i&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;Lines
       of Credit&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       Under the terms of an agreement with PMB LLC, we agreed to
       extend to PMB LLC a $10.0&amp;#160;million line of credit at an
       interest rate equal to LIBOR plus 175&amp;#160;basis points to fund
       certain costs of PMB LLC with respect to the proposed
       development of multi-tenant medical office buildings. During
       2010 and 2009, we funded $1.7&amp;#160;million and
       $3.2&amp;#160;million,
   respectively, under the line of credit. As of December&amp;#160;31,
       2010 and 2009, $4.9&amp;#160;million and $3.2&amp;#160;million,
       respectively, was outstanding and is included in the caption
       &amp;#8220;Other assets&amp;#8221; on our consolidated balance sheets.
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       We entered into an agreement with PMB LLC, the manager of PMB
       Pomona LLC, to extend up to $3.0&amp;#160;million of funding at an
       interest rate of 7.25%, which was secured by 100% of the
       membership interests in PMB Pomona LLC (see Note&amp;#160;22).
       During 2010 and 2009, we funded $0.3&amp;#160;million and
       $1.6&amp;#160;million, respectively. The total $1.9&amp;#160;million was
       repaid during 2010. No further disbursements will be made under
       the agreement.
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       As of February&amp;#160;1, 2010, in connection with the formation of
       Gilbert JV, a consolidated joint venture, we agreed to loan
       Gilbert JV up to $8.8&amp;#160;million as project financing at an
       interest rate of 7.00%, including $6.8&amp;#160;million that was
       disbursed initially and remains outstanding at December&amp;#160;31,
       2010 (see Note&amp;#160;5).
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       As of March&amp;#160;1, 2010, in connection with the formation of
       Pasadena JV, a consolidated joint venture, we agreed to loan
       Pasadena JV up to $56.5&amp;#160;million as project financing at an
       initial interest rate equal to the greater of 3.50% or LIBOR
       plus 165&amp;#160;basis points (increasing to the greater of 5.125%
       or LIBOR plus 375&amp;#160;basis points as of April&amp;#160;1, 2010),
       including $49.8&amp;#160;million that was disbursed initially and
       remains outstanding at December&amp;#160;31, 2010 (see Note&amp;#160;5).
   &lt;/div&gt;
   &lt;div style="margin-top: 12pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 2%; margin-right: 0%; font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent"&gt;
       &lt;b&gt;&lt;i&gt;&lt;font style="font-family: 'Times New Roman', Times"&gt;Indemnities&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;
   &lt;/div&gt;
   &lt;div style="margin-top: 6pt; font-size: 1pt"&gt;&amp;#160;
   &lt;/div&gt;
   &lt;div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent"&gt;
       We have entered into indemnification agreements with those
       partners who contributed appreciated property into NHP/PMB.
       Under these indemnification agreements, if any of the
       appreciated real estate contributed by the partners is sold by
       NHP/PMB in a taxable transaction within a specified number of
       years after the property was contributed, we will reimburse the
       affected partners for the federal and state income taxes
       associated with the pre-contribution gain that is specially
       allocated to the affected partner under the Code. We have no
       current plans to sell any of these properties.
   &lt;/div&gt;
   &lt;/div&gt;
</NonNumbericText><NonNumericTextHeader>&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;
   &lt;!-- Begin Block Tagged Note</NonNumericTextHeader><FootnoteIndexer /><CurrencyCode /><CurrencySymbol /><IsIndependantCurrency>false</IsIndependantCurrency><ShowCurrencySymbol>false</ShowCurrencySymbol><DisplayDateInUSFormat>false</DisplayDateInUSFormat><hasSegments>false</hasSegments><hasScenarios>false</hasScenarios></Cell></Cells><OriginalInstanceReportColumns /><Unit>Other</Unit><ElementDataType>us-types:textBlockItemType</ElementDataType><SimpleDataType>string</SimpleDataType><ElementDefenition>Includes disclosure of commitments and contingencies. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables.</ElementDefenition><ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name FASB Interpretation (FIN)
 -Number 14
 -Paragraph 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 5
 -Paragraph 9, 10, 11, 12

</ElementReferences><IsTotalLabel>false</IsTotalLabel><IsEPS>false</IsEPS><Label>Commitments and Contingencies</Label></Row></Rows><Footnotes /><NumberOfCols>1</NumberOfCols><NumberOfRows>2</NumberOfRows><ReportName>Commitments and Contingencies</ReportName><MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel><SharesRoundingLevel>UnKnown</SharesRoundingLevel><PerShareRoundingLevel>UnKnown</PerShareRoundingLevel><ExchangeRateRoundingLevel>UnKnown</ExchangeRateRoundingLevel><HasCustomUnits>false</HasCustomUnits><SharesShouldBeRounded>true</SharesShouldBeRounded></InstanceReport>
